AVCR logo

Avricore Health Inc. Stock Price

TSXV:AVCR Community·CA$5.6m Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 2 Fair Values set on narratives written by author

AVCR Share Price Performance

CA$0.05
-0.01 (-16.67%)
CA$0.05
-0.01 (-16.67%)
Price CA$0.05

AVCR Community Narratives

There are no narratives available yet.

Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Flawless balance sheet with very low risk.

2 Risks
0 Rewards

Avricore Health Inc. Key Details

CA$3.1m

Revenue

CA$1.8m

Cost of Revenue

CA$1.3m

Gross Profit

CA$2.8m

Other Expenses

-CA$1.4m

Earnings

Last Reported Earnings
Jun 30, 2025
Next Reporting Earnings
n/a
-0.014
42.97%
-46.38%
0%
View Full Analysis

About AVCR

Founded
1996
Employees
n/a
CEO
Rodger Seccombe
WebsiteView website
avricore.com

Avricore Health Inc. engages in the health data and point-of-care technologies business. It provides HealthTab, a turnkey point-of-care testing platform for pharmacies that can test up to 27 biomarkers on the spot for screening and managing chronic conditions, such as diabetes. The company was formerly known as Vanc Pharmaceuticals Inc. and changed its name to Avricore Health Inc. in October 2018. Avricore Health Inc. was founded in 1996 and is based in Vancouver, Canada.

Recent AVCR News & Updates

Recent updates

No updates